These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38057661)

  • 1. TAF15 amyloid filaments in frontotemporal lobar degeneration.
    Tetter S; Arseni D; Murzin AG; Buhidma Y; Peak-Chew SY; Garringer HJ; Newell KL; Vidal R; Apostolova LG; Lashley T; Ghetti B; Ryskeldi-Falcon B
    Nature; 2024 Jan; 625(7994):345-351. PubMed ID: 38057661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
    Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
    Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
    Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP.
    Arseni D; Chen R; Murzin AG; Peak-Chew SY; Garringer HJ; Newell KL; Kametani F; Robinson AC; Vidal R; Ghetti B; Hasegawa M; Ryskeldi-Falcon B
    Nature; 2023 Aug; 620(7975):898-903. PubMed ID: 37532939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C.
    Arseni D; Nonaka T; Jacobsen MH; Murzin AG; Cracco L; Peak-Chew SY; Garringer HJ; Kawakami I; Suzuki H; Onaya M; Saito Y; Murayama S; Geula C; Vidal R; Newell KL; Mesulam M; Ghetti B; Hasegawa M; Ryskeldi-Falcon B
    Nature; 2024 Oct; 634(8034):662-668. PubMed ID: 39260416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of pathological TDP-43 filaments from ALS with FTLD.
    Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
    Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
    Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
    Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
    Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
    Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
    Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
    Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage.
    Deng Q; Holler CJ; Taylor G; Hudson KF; Watkins W; Gearing M; Ito D; Murray ME; Dickson DW; Seyfried NT; Kukar T
    J Neurosci; 2014 Jun; 34(23):7802-13. PubMed ID: 24899704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
    Mackenzie IR; Neumann M
    Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.
    Jiang YX; Cao Q; Sawaya MR; Abskharon R; Ge P; DeTure M; Dickson DW; Fu JY; Ogorzalek Loo RR; Loo JA; Eisenberg DS
    Nature; 2022 May; 605(7909):304-309. PubMed ID: 35344984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
    Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
    Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.